| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0003060> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0005567> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0013813> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0042720> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0042769> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0042776> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0043529> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0082774> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0600363> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C0600364> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C2350597> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C3658355> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33569817_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Fundación IMDEA-Nanociencia, Madrid, Spain.\', \'Nanobiotecnología (IMDEA-Nanociencia), Unidad Asociada al Centro Nacional de Biotecnología (CSIC), Madrid, Spain.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Escalona-Noguero_Carmen> <https://research.tib.eu/covid-19/entity/L%C3%B3pez-Valls_Mar%C3%ADa> <https://research.tib.eu/covid-19/entity/Sot_Bego%C3%B1a>
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/bies.202000315>
?:doi	10.1002/bies.202000315
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t> <https://research.tib.eu/covid-19/entity/Review>
?:journal	BioEssays : news and reviews in molecular, cellular and developmental biology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33569817> <https://research.tib.eu/covid-19/entity/r1oe4rwt>
?:pmid	<https://research.tib.eu/covid-19/entity/33569817>
?:pmid	33569817
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	CRISPR/Cas technology as a promising weapon to combat viral infections.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33569817>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33569817>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all